News | January 21, 2026
Neurizon locks in global trademark protection across key pharma markets
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
CystoSmart, an AI tool designed to detect bladder tumors during screening and surveillance cystoscopy, is brand-agnostic and works with flexible, rigid, and single-use scopes
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
Hansoh Pharma will receive an upfront payment in the low double-digit millions
All pending litigation between Biocon Biologics, Regeneron, and Bayer will be dismissed
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
The project focuses on recovering high-quality polycarbonate, a valuable polymer material used in the construction of the filters
Captured microbes are then neutralized on engineered microbicidal surfaces
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Subscribe To Our Newsletter & Stay Updated
